|
|||
| CMS to Consider Coverage of F-18 PET Bone Scans The Centers for Medicare and Medicaid Services (CMS) has posted a National Coverage Analysis (NCA) tracking sheet for “Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer”. Currently the Medicare National Coverage Determination (NCD) manual for PET identifies FDG as the only nationally covered radioisotope for use in PET for cancer imaging. CMS is reconsidering that policy and has started the process to review evidence on the use of sodium fluoride F-18 (NaF-18) to identify bone metastasis of cancer. A positive coverage decision would lead to reimbursement by Medicare for PET bone scans using NaF-18. To help with its analysis, CMS is soliciting public comments through July 4, 2009. CMS considers all public comments, and is particularly interested in clinical studies and other scientific information relevant to the technology under review. The proposed decision memo due date is 12/4/09 The expected NCA completion date (final decision) is 3/4/2010 The NCA tracking sheet can be found at: www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=233 Public comments for this NCA may be submitted at: www.cms.hhs.gov/mcd/public_comment.asp
Reimbursement information is provided by Cardinal Health as general coding and payment information. This information is not intended to replace or serve as substitute for your duty to verify that such information is proper for your particular circumstances. Any codes reported should accurately reflect the procedures performed and the patient’s conditions. You may want to consult with local payers to confirm compliance with local policies, or otherwise review and confirm reimbursement policies with your own legal or other professional advisors. |
|||
